Experience of clinical use of the Odstock dropped foot stimulator
Authors: Burridge, J., Taylor, P., Hagan, S. and Swain, I.
Journal: Artificial Organs
Volume: 21
Issue: 3
Pages: 254-260
ISSN: 0160-564X
DOI: 10.1111/j.1525-1594.1997.tb04662.x
Abstract:The Odstock dropped foot stimulator (ODFS) is a simple functional electrical stimulation (FES) device for the correction of dropped foot. Improved reliability, fine control of stimulation parameters, and careful application and follow-up have led to 86% compliance. Data on 56 patients (50 patients with hemiplegia, 5 patients with multiple sclerosis, and 1 patient with spinal cord injury) who have used the system for between 6 and 18 months are presented and show a statistically significant increase in walking speed with the stimulator at 3 months of 14% (p < 0.001); decreased effort of walking, measured as physiological cost index (PCI), of 37% (p < 0.001); and statistically significant improvement in functional mobility tests and questionnaires. No statistically significant carryover was seen although 3 patients had sufficient improvement in active ankle control and gait parameters to no longer need the stimulator. Six patients who used the stimulator all day every day had a problem with skin irritation, which we have not yet been able to solve. Two patients discontinued use after experiencing increased spasticity in the calf.
Source: Scopus
Experience of clinical use of the Odstock dropped foot stimulator.
Authors: Burridge, J., Taylor, P., Hagan, S. and Swain, I.
Journal: Artif Organs
Volume: 21
Issue: 3
Pages: 254-260
ISSN: 0160-564X
DOI: 10.1111/j.1525-1594.1997.tb04662.x
Abstract:The Odstock dropped foot stimulator (ODFS) is a simple functional electrical stimulation (FES) device for the correction of dropped foot. Improved reliability, fine control of stimulation parameters, and careful application and follow-up have let to 86% compliance. Data on 56 patients (50 patients with hemiplegia, 5 patients with multiple sclerosis, and 1 patient with spinal cord injury) who have used the system for between 6 and 18 months are presented and show a statistically significant increase in walking speed with the stimulator at 3 months of 14% (p < 0.001); decreased effort of walking, measured as physiological cost index (PCI), of 37% (p < 0.001); and statistically significant improvement in functional mobility tests and questionnaires. No statistically significant carryover was seen although 3 patients had sufficient improvement in active ankle control and gait parameters to no longer need the stimulator. Six patients who used the stimulator all day every day had a problem with skin irritation, which we have not yet been able to solve. Two patients discontinued use after experiencing increased spasticity in the calf.
Source: PubMed
Preferred by: Ian Swain
Experience of clinical use of the Odstock dropped foot stimulator
Authors: Burridge, J., Taylor, P., Hagan, S. and Swain, I.
Journal: ARTIFICIAL ORGANS
Volume: 21
Issue: 3
Pages: 254-260
ISSN: 0160-564X
DOI: 10.1111/j.1525-1594.1997.tb04662.x
Source: Web of Science (Lite)
Experience of clinical use of the Odstock dropped foot stimulator.
Authors: Burridge, J., Taylor, P., Hagan, S. and Swain, I.
Journal: Artificial organs
Volume: 21
Issue: 3
Pages: 254-260
eISSN: 1525-1594
ISSN: 0160-564X
DOI: 10.1111/j.1525-1594.1997.tb04662.x
Abstract:The Odstock dropped foot stimulator (ODFS) is a simple functional electrical stimulation (FES) device for the correction of dropped foot. Improved reliability, fine control of stimulation parameters, and careful application and follow-up have let to 86% compliance. Data on 56 patients (50 patients with hemiplegia, 5 patients with multiple sclerosis, and 1 patient with spinal cord injury) who have used the system for between 6 and 18 months are presented and show a statistically significant increase in walking speed with the stimulator at 3 months of 14% (p < 0.001); decreased effort of walking, measured as physiological cost index (PCI), of 37% (p < 0.001); and statistically significant improvement in functional mobility tests and questionnaires. No statistically significant carryover was seen although 3 patients had sufficient improvement in active ankle control and gait parameters to no longer need the stimulator. Six patients who used the stimulator all day every day had a problem with skin irritation, which we have not yet been able to solve. Two patients discontinued use after experiencing increased spasticity in the calf.
Source: Europe PubMed Central